OAC
PALI icon

OMERS Administration Corp’s Palisade Bio PALI Stock Holding History

OMERS Administration Corp’s Portfolio PALI Stock Details PALI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-83,300
Closed -$146K – 1080
2026
Q1 		$146K Sell
83,300
-24,700
-23% -$44.9K ﹤0.01% 965
2025
Q4 		$254K Buy
+108,000
New +$208K ﹤0.01% 856

Other funds holding PALI

SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
BGI
B Group Inc Dallas, Texas $213M AUM 96.05% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

OMERS Administration Corp's PALI Position: Q2 2026 in Review

OMERS Administration Corp sold out of Palisade Bio (PALI) in Q2 2026, closing a stake of 83,300 shares — an estimated $146K sold.

OMERS Administration Corp first reported a position in PALI in Q4 2025 and held it in 2 quarters. The position peaked at $254K in Q4 2025. 124 funds tracked by Wall St. Rank hold PALI as of Q2 2026.

  • OMERS Administration Corp reported no remaining Palisade Bio position as of Q2 2026 after selling out during the quarter.
  • OMERS Administration Corp sold 83,300 Palisade Bio shares in Q2 2026, an estimated $146K.
  • OMERS Administration Corp first reported a position in Palisade Bio in Q4 2025 and held it in 2 quarters.
  • OMERS Administration Corp's Palisade Bio position peaked at $254K in Q4 2025.
  • 124 funds tracked by Wall St. Rank held Palisade Bio as of Q2 2026.

Based on OMERS Administration Corp's 13F filing for Q2 2026, filed 13 Aug 2026.